Federal Strategic Benefits. Because

Federal Strategic Benefits. Because comprehensive, government-wide strategic planning at the federal level is still in its early stages, most of the findings focus on individual agencies. The U.S. Food and Drug Administration (FDA), which has tried to develop “an orderly, analytical vision of the future” (which comes awfully close to being a strategic plan), may phrase the utility of public strategic planning best: “The bas news” is that the FDA’s initiative produced “only modest increases in rationality under particular circumstances, [but] the good news is that increases of any size are so rare that any success in newsworthy”; the bad news is that the effort “is likely to be resource intensive and fraught with hazards….The good news is that the results of the process are likely to have valuable anticipated and unanticipated uses.”81